Top Device Companies

Masimo Lowers Expectations As Hospitals Cut Device-Buying Costs

Masimo says it has suffered by cutbacks at hospitals during the current economic crisis and must reduce expectations for its monitors and other products. Masimo now expects no more than $18 million in sales of its latest Rainbow line device, a drop from a previous forecast for as much as $25 million in sales. CEO Joe Kiani said the current environment "does not bode as well" for new devices. (Click here for more)

"Masimoís Latest Device Hits Some Hospital Resistance" - Orange County Business Journal (8/17/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Respironics, Masimo Settle Suits Over Monitoring Device Technology

Respironics and Masimo have settled a lawsuit surrounding monitoring device technology, with each dropping claims against the other. Under the agreement, Masimo has agreed to a scheculed phase-out of its MRS oximetry technology, although the settlement said Masimo’s devices to measure blood constituents non-invasively do not use the technology in dispute. Respironics is a subsidiary of Royal Philips Electronics. (Click here for more)

"Masimo Settles Suit With Philips" – Reuters (7/17/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Masimo Declares Full Launch Of Hemoglobin Monitor

Masimo Corp. has launched globally its non-invasive continuous hemoglobin monitor, considered the first of its kind to receive FDA approval. The Masimo SpHb had been released in limited markets, including 40 hospitals on four continents, since last September. The device allows continuous and immediate measurements of hemoglobin to provide prompt detection of internal bleeding and other problems. (Click here for more)

“If It’s In Your Blood, Irvine’s Masimo Knows” – Orange County Metro (3/23/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Masimo Device Said To Improve Detection Of Heart Problems In Newborns

Masimo Corporation, which makes medical monitoring equipment, has produced a device to enhance the accuracy of pulse oximetry screening to detect congenital heart disease in newborns. A published study credited the Masimo pulse-oximetry device for greater accuracy in diagnosing the infants. The report noted that as many as 30 percent of newborns who die of heart disease were not diagnosed in advance. The Masimo device increased the accuracy by about 20 percent, the study said. (Click here for more)

“Irvine-Based Masimo Produces Life-Saving Device For Newborns” – OC Metro (2/1/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com